65.76MMarket Cap-0.50P/E (TTM)
5.150High4.880Low38.28KVolume5.150Open5.050Pre Close191.16KTurnover0.92%Turnover RatioLossP/E (Static)13.34MShares19.99952wk High0.55P/B20.62MFloat Cap4.57552wk Low--Dividend TTM4.18MShs Float171.799Historical High--Div YieldTTM5.35%Amplitude4.575Historical Low4.993Avg Price1Lot Size
OnKure Therapeutics Stock Forum
Onkure Therapeutics Inc - Oki-219 Well Tolerated With No Hyperglycemia and Only Grade 1 Traes
SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(9.9%),Citadel Advisors LLC(9.8%), etc.
SEC 17:29
SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(14.98%),Bihua Chen(14.98%), etc.
SEC 16:24
SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L...
No comment yet